Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban sotorasib interaction study (ROSIE-study)
2023-505557-41-00Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of rivaroxaban and sotorasib, sponsored by Radboud University Medical Center. Started Nov 2023; status: completed.
02
Drugs
rivaroxabansotorasib
Beyond the preview
Go deeper on 2023-505557-41-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-505557-41-00.